Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$7.89 - $13.14 $155,630 - $259,186
-19,725 Reduced 31.08%
43,745 $557,000
Q3 2023

Nov 14, 2023

SELL
$9.88 - $14.0 $41,120 - $58,268
-4,162 Reduced 6.15%
63,470 $655,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $200,540 - $253,930
-18,603 Reduced 21.57%
67,632 $886,000
Q1 2023

May 15, 2023

SELL
$7.49 - $12.54 $173,071 - $289,761
-23,107 Reduced 21.13%
86,235 $964,000
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $315,593 - $1.11 Million
64,145 Added 141.92%
109,342 $921,000
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $693,773 - $1.08 Million
45,197 New
45,197 $753,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $309M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.